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Abstract
Background: Resistance to 3rd-generation cephalosporins in Escherichia coli is mostly mediated by extended-spectrum
beta-lactamases (ESBLs) or AmpC beta-lactamases. Besides overexpression of the species-specific chromosomal ampC
gene, acquisition of plasmid-encoded ampC genes, e.g. blaCMY-2, has been described worldwide in E. coli from humans
and animals. To investigate a possible transmission of blaCMY-2 along the food production chain, we conducted a next-
generation sequencing (NGS)-based analysis of 164 CMY-2-producing E. coli isolates from humans, livestock animals and
foodstuff from Germany.
Results: The data of the 164 sequenced isolates revealed 59 different sequence types (STs); the most prevalent ones
were ST38 (n = 19), ST131 (n = 16) and ST117 (n = 13). Two STs were present in all reservoirs: ST131 (human n = 8; food
n = 2; animal n = 6) and ST38 (human n = 3; animal n = 9; food n = 7). All but one CMY-2-producing ST131 isolates
belonged to the clade B (fimH22) that differed substantially from the worldwide dominant CTX-M-15-producing clonal
lineage ST131-O25b clade C (fimH30). Plasmid replicon types IncI1 (n = 61) and IncK (n = 72) were identified for the
majority of blaCMY-2-carrying plasmids. Plasmid sequence comparisons showed a remarkable sequence identity,
especially for IncK plasmids. Associations of replicon types and distinct STs were shown for IncK and ST57, ST429 and
ST38 as well as for IncI1 and ST58. Additional β-lactamase genes (blaTEM, blaCTX-M, blaOXA, blaSHV) were detected in 50%
of the isolates, and twelve E. coli from chicken and retail chicken meat carried the colistin resistance gene mcr-1.
Conclusion: We found isolates of distinct E. coli clonal lineages (ST131 and ST38) in all three reservoirs. However, a direct
clonal relationship of isolates from food animals and humans was only noticeable for a few cases. The CMY-2-producing
E. coli-ST131 represents a clonal lineage different from the CTX-M-15-producing ST131-O25b cluster. Apart
from the ST-driven spread, plasmid-mediated spread, especially via IncI1 and IncK plasmids, likely plays an
important role for emergence and transmission of blaCMY-2 between animals and humans.
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Background
The production of extended-spectrum β-lactamases
(ESBLs) is the worldwide most important mechanism of
resistance to 3rd-generation cephalosporins in Escherichia
coli. [1]. AmpC beta-lactamases are also able to hydrolyse
3rd-generation cephalosporins. Induction or overexpression
of chromosomally-located, species-specific ampC genes and
the acquisition of plasmid-encoded ampC genes (e.g. blaC-
MY-like, blaACC-like, blaDHA-like) have been described in E. coli
[2]. The most common plasmidic ampC gene reported in
Enterobacteriaceae including E. coli is blaCMY-2 [3, 4]. It orig-
inates from the chromosomal ampC gene of Citrobacter
freundii, and had been mobilized onto plasmids of different
replicon types (IncK, IncI1, IncA/C and IncFIA-FIB) by the
insertion sequence (IS) ISEcp1 that also provides the promo-
tor for high-level expression of blaCMY-2 [2].
In recent years an increasing number of CMY-2-producing
E. coli was noticed in the European livestock production.
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Especially in poultry, there is a prevalence of more than 30%
among 3rd-generation cephalosporin-resistant E. coli,
whereas only ~ 1% of the 3rd-generation cephalosporin-re-
sistant E. coli from humans harboured the blaCMY-2 gene [3,
5, 6]. Recent studies reported the finding of blaCMY-2 on
similar IncK or IncI1 plasmids in unrelated E. coli isolates
from poultry and other livestock animals, meat products,
humans and companion animals [7–10]. This finding points
towards a zoonotic potential for the dissemination of this re-
sistance determinant via the food production chain. In recent
years, a big variety of clonal lineages of E. coli has been re-
ported worldwide, some of them have proved to be domin-
ant. Of interest are ESBL-producing E. coli of sequence type
(ST)131 that are prevalent in humans but not in livestock an-
imals and food [3, 11, 12]. Using sequence based analyses
ST131 has been grouped into different clades, which are usu-
ally associated with specific fimH alleles: clade A (fimH41
ST131-O16), clade B (fimH22 ST131-O25b) and clade C
(fimH30 including ST131-O25b fimH30-R/fimH30-Rx)
[13, 14]. Especially strains of ST131-O25b with presence
of ESBL-type CTX-M-15 and resistance to fluoroquino-
lones (fimH30-Rx) have been reported worldwide, and fre-
quently represent a cause of infections, particularly urinary
tract infections, in human patients [15, 16]. However,
CMY-2 production has been hitherto rarely described for
ST131 isolates [7, 17].
To investigate a possible transmission of blaCMY-2 along
the food production chain, we conducted next-generation se-
quencing (NGS)-based analysis of CMY-2-producing E. coli
isolates from humans, livestock animals and foodstuff from
Germany.
Results
Antibiotic susceptibilities, resistance and virulence genes
All 164 CMY-2-producing E. coli isolates of our study
were resistant to ampicillin, cefotaxime, ceftazidime and
cefoxitin but remained susceptible to imipenem and mer-
openem with one exception (isolate no. 10–16 with
non-susceptibility to imipenem and meropenem). Add-
itional resistance to ciprofloxacin was detected in 25%
(41/164) of the isolates. The proportion of resistance to
ciprofloxacin in CMY-2-producing E. coli from humans
was 43.5% (20/46) remarkably higher than with 17.8% (21/
118) in isolates from livestock animals and meat products.
Presence of resistance genes in the whole genome se-
quences of the 164 E. coli isolates was investigated by
ResFinder (Additional file 1: Table S1). All genomes con-
tained blaCMY-2. Additional β-lacatamase genes were
present quite frequently: blaTEM-like (n = 72), blaCTX-M-1/
9-group (n = 8), blaOXA-1-like (n = 5), blaSHV-like (n = 5) and
blaOXA-10-like (n = 1). Several isolates carried plasmid-
mediated quinolone resistance (PMQR) genes that con-
tribute to ciprofloxacin-resistance: aac(6′)-Ib-cr (n = 7),
qnrS1 (n = 4), qnrB1 (n = 1), and qnrB19 (n = 1).
Furthermore, the plasmid-mediated colistin resistance
gene mcr-1 was observed in twelve isolates from live-
stock animals (chickens n = 3; pigs n = 5; turkey n = 1)
and food (n = 3). Subsequently performed susceptibility
tests (broth microdilution test according to EUCASTcriteria
v. 7.1) confirmed resistance to colistin (MIC 4–8 mg/L) of
these 12 isolates.
Additionally, the presence of shigatoxin gene stx-2 was
observed in one isolate (isolate no 6–16, serotype
O141:H49).
MLST analysis
Our collection of 164 blaCMY-2-positive E. coli isolates
showed a high diversity of sequence types (ST). For isolates
from human patients (n= 46), isolates from livestock animals
(n= 63), and isolates from food (n= 55) we determined 31,
29, and 20 different STs, respectively (Table 1). The most
prevalent STs were ST38 (n= 19), ST131 (n= 14) and ST117
(n= 14). In isolates from human patients the most prevalent
ST was ST131 (n= 6; 13%), its proportion among isolates
from livestock animals and food was 12.2 and 3.8%, respect-
ively. However, in isolates from livestock animals and food
products ST38 was most prevalent (chicken meat n= 9;
chickens n= 6; cattle n= 1). Several STs were present in E.
coli from all three sources: ST38 (humans n= 3; chicken
meat n = 9; chickens n = 6; cattle n = 1), ST131 (humans
n = 6; chicken meat n = 2; chickens n = 5; turkey n = 1),
ST117 (human n = 1; chicken meat n = 5; turkey meat
n = 1; chickens n = 7) and ST10 (humans n = 4; chicken
meat n = 1; turkey meat n = 1; pig meat n = 2; chickens
n = 1; pigs n = 1). In contrast, other STs, e.g. ST429,
were only observed in chicken meat products and
chicken isolates (n = 3/3) (Table 1).
cgMLST analysis
The application of a core genome multilocus sequence
typing (cgMLST) scheme achieved a much higher reso-
lution (comparison of 2547 alleles vs. seven MLST al-
leles) regarding the genetic relatedness of the
CMY-2-producing E. coli isolates. As expected, isolates
forming one ST by the classical multilocus sequence typ-
ing (MLST) scheme grouped together in the cgMLST
scheme, but due to the higher discrimination capability
of the cgMLST, subgroups within the respective
cgMLST cluster were observed (Fig. 1). The highest di-
versity was observed for ST10 isolates; the allele differ-
ences between ST10s isolates varied between 326 and
982). In general, isolates from the same source (human,
livestock animal or food) grouped more closely together,
but also clusters of isolates from animals and meat prod-
ucts could be observed, e.g. ST117 and ST2040 (Fig. 1).
Most isolates from human patients showed a noticeably
higher allele distance to isolates from livestock animals
and food. Exceptions were observed for ST131 and
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ST1463. ST131 isolates from the three sources grouped
into mixed clades with an allele difference of 15–205. In
contrast, ST38 isolates from human patients separated
from the livestock/food isolates by a minimum of 513
alleles, whereas the difference between livestock and
food isolates was 1–190 alleles. The most related isolates
were identified in ST429 (livestock/food isolates, allele
difference 0–46), ST117 and ST3778 (allele difference
0–79). ST117 and ST3778 differ in three nucleotide sub-
stitutions in the gyr allele (gyr4- > gyr14: 174C > T;
288C > T; 396 T > C), and therefore, form one group in
the cgMLST scheme. All but one (isolate no. 473–14,
human tracheal secretion isolate) isolate of these two
STs were from livestock (chickens n = 10; pig n = 1) and
food (chicken meat n = 5; turkey meat n = 1).
In an additional analysis we compared our ST429 iso-
lates to all available ST429 E. coli isolates from EnteroBase
(http://enterobase.warwick.ac.uk/). Our cgMLST analysis
demonstrated that a cluster of E. coli isolates from chicken
meat products and chicken from Denmark, Germany and
Table 1 Multilocus sequence typing (MLST) of 164 CMY-2-producing Escherichia coli from different sources, 2008-2013, Germany
MLST E. coli
human patients
MLST E. coli from food MLST E. coli from livestock animals
chicken turkey pork chicken turkey pig cattle
ST n ST n ST n ST n ST n ST n ST n ST n
ST131 6 (13.0%) ST38 9 ST10 1 ST10 2 ST117 6 ST1196 3 ST1196 3 ST88 1
ST10 4 ST58 5 ST5763 1 ST75 1 ST38 6 ST212 1 ST38 1
ST69 3 ST57 5 ST2040 1 ST131 5 (12.2%) ST10 1
ST38 3 ST117 5 ST117 1 ST3778 4 ST3778 1
ST354 2 ST69 4 ST6008 1 ST429 3 ST57 1
ST58 2 ST429 3 ST421 1 ST57 3 ST1594 1
ST453 2 ST2040 3 ST1463 1 ST2040 3 ST2040 1
ST1844 1 ST68 2 ST420 1
ST59 1 ST131 2 (3.8%) ST1158 1
ST141 1 ST155 2 ST540 1
ST744 1 ST569 1 ST1196 1
ST224 1 ST1286 1 ST155 1
ST4759 1 ST420 1 ST2309 1
ST23 1 ST10 1 ST162 1
ST117 1 ST4937 1 ST2458 1
ST2450 1 ST1818 1 ST354 1
ST448 1 ST115 1 ST10 1
ST348 1 ST1594 1 ST212 1
ST457 1 ST373 1
ST86 1 ST108 1
ST1463 1 ST752 1
ST93 1 ST350 1









Total 46 53 7 3 41 3 9 2
Proportion of the most frequent sequence type ST131 in the respective source is given in %
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France showed a high genetic relatedness (Additional file 2:
Figure S1).
SNP analysis
Isolates from selected cgMLST clusters (ST131, ST1196,
ST429 and ST117/3778) were analysed by a single nu-
cleotide polymorphisms (SNP)-based mapping approach.
For each cgMLST cluster the best fitting reference for
the mapping-based SNP analysis was identified using
refRank. E. coli strain MDR_56 (GenBank accession no.
NZ_CP019903.1) was determined as the best available
reference for ST117/ST3778. The analysis of ST117/
ST3778 isolates revealed three clusters with differences
from 0 to 47 SNPs in each cluster (Additional file 3:
Figure S2a). Notably, cluster A (ST3778) isolates no.
510–16 and 484–16 from different farms in the federal
state of Brandenburg showed no SNPs (exclusion
distance d = 0) and originated from chicken faeces (iso-
lated in 2011) and an environmental sample from a pig
farm (isolated 2011) within a distance of ca. 50 km. An-
other isolate (no. 485–16) from chicken faeces, isolated
in 2011 in the federal state Saxony-Anhalt, represented a
single allele difference and only four SNPs compared to
isolates no. 510–16 and 484–16. Cluster B and C equally
presented closely related ST117 isolates (3–20 SNPs in
cluster B and 11–33 SNPs in cluster C observed) and
originated from chicken (n = 4) and chicken meat (n = 1)
and turkey meat (n = 1), isolated in 2012 in the federal states
Lower Saxony and Hesse (Additional file 3: Figure S2a).
Within ST131, three closely related isolates from live-
stock in farms of different federal states (all isolated 2012)
were observed: no. 464–16 (chicken, Lower-Saxony), no.
500–16 (turkey, Bavaria) and no. 495–16 (chicken,
Bavaria) demonstrating 0 (no. 464–16 to no. 500–16) to 3
Fig. 1 NGS-based neighbour-joining tree of 164 E. coli isolates based on an ad-hoc cgMLST including 2547 alleles. The tree was built with
SeqSphere+ and visualized by iTOL v.3. Different MLST clusters are highlighted with dark/light grey shadows. The color-coded rings represent the
origins of the samples (inner ring) and the corresponding replicon types to the present blaCMY-2 carrying plasmids (outer rings)
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(no. 500–16 to no. 495–16) allele differences and 1 to 6
SNPs differences, respectively (Additional file 3: Figure
S2b). Interestingly, two isolates from human patients (no.
399–15 and no. 1045–14; isolated in November 2013 and
August 2014) differed by only 28 and 27 SNPs, respectively,
from a chicken isolate (no. 468–16, isolated in August
2012). These three closely related isolates were collected in
Western Germany (radius 200 km) within a period of three
years indicating a trans-sectoral spread.
The seven identified isolates assigned to ST1196 repre-
sented closely related strains from livestock animals, varying
from 0 to 125 allele differences in the cgMLST scheme and
grouping into two clusters (Additional file 3: Figure S2c).
Cluster A included three isolates from turkeys. These iso-
lates were collected in three stables from two farms in the
same federal state in 2014. Differences between the isolates
were from 1 to 3 alleles and 0 to 3 SNPs (by mapping
against for ST1196 isolates best determined reference
NC_020518.1 E. coli str. K-12 substr. MDS42). Cluster B
consisted of three isolates from pigs, isolated in the federal
states North Rhine-Westphalia and Saxony-Anhalt in 2011,
showing 0 allele and 0 to 2 SNPs differences. One additional
isolate from chicken (no. 472–16) was sampled in 2011 in
the same geographical region as the pig isolates (cluster B)
but differed by 99 SNPs or by 88 alleles to cluster A isolates.
The two closely related ST1463 isolates from human
and turkey meat, respectively, exhibited high similarity in
the cgMLST approach (19 allele differences), and only
21 SNPs were detected after mapping (for ST1463 iso-
lates best determined reference: GenBank accession no.
NC_020518.1, data not shown). The isolates were identi-
fied in Bavaria and North Rhine-Westphalia in the years
2012 and 2014, respectively.
All E. coli-ST429 isolates were from livestock animals and
food and showed only a small number of allele variants
(Additional file 3: Figure S2d). Two isolates from chickens
were collected in the same federal state within a 16 month
period between 2011 and 2012 and showed 0 allele and 0
SNP differences. Isolates from chicken meat - which were re-
covered from meat products bought 2012 in Lower Saxony
and Bavaria - presented only 6 and 8 alleles difference, re-
spectively, to the other isolates of this ST from chicken. Fur-
thermore, isolate no. 8–16 from a diseased chicken (isolated
in 2012 in Bavaria) showed a slightly distant similarity (32 to
46 allele differences) to all other E. coli-ST429 isolates.
fimH analysis of ST131-E. coli isolates
Typing of the fimH gene of E. coli can be used to eluci-
date the population structure within a ST and is used to
differentiate the subclades of ST131 [12]. Our analysis
showed that all but one CMY-2-producing ST131-E. coli
(n = 14) belonged to the clade B, and were associated
with fimH22. The exceptional isolate no. 177–10 (human
origin) harboured fimH30 (clade C) instead and carried
an additional ESBL gene blaCTX-M-15. Isolates belonging to
clade A (fimH41) were not identified. Sequence data sug-
gested a plasmid location of blaCMY-2 in isolate 177–10 but
not on an IncI1 or IncK2 plasmid as found for most CMY-2
E. coli isolates in our study (see below). A screening of nearly
1000 available E. coli-ST131 sequences from the years 2008
to 2017 (sequences were obtained from the International
Nucleotide Sequence Database Collaboration (INSDC) by
the SS+ NCBI Bacteria Genome Browser and E. coli assem-
blies from EnteroBase (http://enterobase.warwick.ac.uk/spe-
cies/index/ecoli)) revealed only 15 blaCMY-2-positive strains
(Additional file 4: Figure S3). The majority (n= 9) of these 15
isolates clustered in the applied cgMLST scheme in clade B
(fimH22), along with our study isolates; only one isolate har-
boured a fimH41 allele (clade A). The remaining five isolates
carried fimH30 (clade C) but no additionally blaCTX-M-15
gene and IncK or IncI1 replicon sequences were present. In
general, most of the compared ST131 isolates from Entero-
Base contained fimH30 with blaCTX-M-15 (n= 377), fimH30
without blaCTX-M-15 (n = 287) or fimH30 with blaCTX-M-27
(n = 87). The fimH variants grouped exclusively according
to their variants in the cgMLST schema. A total of 789
fimH30 isolates were identified, in addition to 66 fimH41,
16 fimH27 and 84 fimH22; most of the blaCMY-2-positive
isolates cluster in the latter clade H22 (Additional file 4:
Figure S3). Isolate no. 177–10 clustered together with
fimH30 ESBL-positive strains in clade C.
Plasmid analysis
In general, the most frequent replicon types identified by
PlasmidFinder were FIB (n= 133), FII (n= 88), FIA (n= 33)
and FIC (n= 55), I1 (n= 81) and B/O/K/Z (n= 78); further
replicon types were A/C (n= 7), N (n= 10) and I2 (n= 12).
Contig aligned to several completely assembled blaCMY-2-car-





In 72 E. coli isolates (human n = 14; livestock n = 25;
food n = 37) blaCMY-2 has been linked to plasmids of the
recently defined incompatibility group IncK2 [8]
(Additional file 1: Table S1). In 26 isolates the link
between blaCMY-2 and the IncK2 replicon sequence was
confirmed on the same de novo assembled contig. In the
remaining 46 isolates multiple occurrences of identical
insertion sequences (IS) in the sequence data prevented
a complete de novo assembly. In this case, a mapping of
contigs to previously published blaCMY-2-carrying plas-
mid sequences (pTMSA1088 and pDV45) was con-
ducted to deduce the respective plasmid contigs. Only
one plasmid backbone with minor (SNPs) and major
(mobile genetic element (MGE) insertions and variable
shufflon region) alterations was identified among all
IncK2 plasmid sequences. This backbone was identical
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to the sequence of the annotated and fully assembled
blaCMY-2-carrying plasmids pDV45 (85.9 kb) and
pTMSA1088 (79.3 kb). These two plasmids differed by a
ca. 6.5 kb sized fragment inserted between the genes
yfbA and psiB and presented a highly variable shufflon
region [8]. We confirmed these plasmid sizes by S1
nuclease pulsed-field gel electrophoresis (PFGE) for
selected isolates of this study. The Inc type was con-
firmed by PBRT [8].
All 72 IncK2 plasmids showed the previously described
genetic environment of blaCMY-2, consisting of ISEcp1 up-
stream and blc and sugE downstream of blaCMY-2 (Fig. 2a)
[18, 19]. However, in two isolates a sequence alteration
was observed: Isolate no. 66–08 showed an insertion
element (ISKpn26-like) integrated between ISEcp1 and
blaCMY-2. Isolate no. 35–16 had a truncated ISEcp1 elem-
ent due to an ISKpn26 integration. Transconjugants har-
bouring both blaCMY-2-carrying plasmids were resistant to
cefotaxime, ceftazidime and cefoxitin confirming the func-
tionality of this beta-lactamase gene despite sequence
alterations upstream of blaCMY-2.
Our genome data showed high nucleotide sequence
identity (99.8–100%) when the shufflon region was ex-
cluded for 13 isolates (human n = 2; poultry n = 5;
poultry meat n = 6) compared with plasmid pTMSA1088
(Genbank accession no: KR905386.1); plasmid sizes
ranged from 79.3 kb to 80.6 kb. Insertion of an IS2
element into different locations of the plasmid sequence
was found in two of the 13 isolates. The majority of
IncK2 plasmids (53/72 isolates) were identical to plasmid
pDV45 (KR905384.1). This highly conserved plasmid
sequence was found in isolates from human patients
(n = 11), broiler chicken (n = 13), pigs (n = 3), broiler
meat (n = 25) and turkey meat (n = 1). A nucleotide
sequence identity of 98.6–100% was observed when
the shufflon region and unique MGEs were excluded.
In eleven of these isolates, the plasmids showed
unique insertion sites of various MGEs (Additional
file 6: Table S2). One isolate (no. 466–16, ST117,
chicken) carried both, a pDV45-like plasmid and an
IncI1 plasmid (type IncI1 pST12b, see below) carrying
blaCMY-2.
Fig. 2 Surrounding genetic regions of blaCMY-2 in the 164 E. coli isolates from the different reservoirs. ISEcp1 and the adjacent from Citrobacter freundii
mobilized conserved chromosomal region containing blaCMY-2, blc, sugE and ecnR is highlighted in dark grey across the different backgrounds. The color
code is as follows: ISEcp1 is in orange, blaCMY-2 in red, blc, sugE, and ecnR are in blue, insertion sequence elements (IS) in brown, E. coli chromosomal genes
adjacent the blaCMY-2 complex integration are in light green. The black rectangles represent the inverted repeats of ISEcp1; further inverted repeats are
highlighted by grey rectangles. a Genetic surrounding of blaCMY-2 found on different plasmid backbones (IncA/C (accession number: CP014658), IncK2
(accession number: KR905384), IncI1-pST2 (accession number: KT186369), IncI1-pST12a (accession number: NC_011077), IncI1-pST12b (accession number:
CP012929)) compared to the genetic surrounding of blaCMY-2 in S. enterica serovar Newport (accession number: DQ164214). b Genetic surrounding of
blaCMY-2 in eight E. coli isolates with chromosomally encoded blaCMY-2. Isolates with twofold encoded blaCMY-2 are indicated by an asterisk, the second copy
was putatively chromosomally integrated. c Putative chromosomal integration of blaCMY-2 in 15 isolates compared to a previously published sequence
(accession number FM246884). The presence of a Shigella flexneri 2a SRL pathogenicity island region downstream of truncated genes blc and yggr is
shown. Isolates with two blaCMY-2 genes (additional putative chromosomal integration site) are indicated by an asterisk, respectively
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In six isolates (all E. coli-ST429; chickens n = 3 and
chicken meat n = 3) the IncK2 plasmid backbone was re-
constructed, but showed an additional unique nucleotide
sequence compared to plasmid pDV45 (Additional file 5:
Figure S4). The plasmid sizes ranged after de novo assem-
bly from 114.5–120 kb (confirmed by S1 nuclease PFGE
for isolate no. 8–16) and varied due to inserted MGEs
(Additional file 6: Table S2). The additional nucleotide se-
quence as compared to pDV45 included an undescribed
TnAs3-like-element, interrupted by an IS1326 element, a
mercury resistance operon, genes encoding plasmid stabil-
ity proteins (stbAB) and a colicin operon.
The plasmid-wide maximum common-gene-approach by
a gene-by-gene comparison was conducted for all IncK2
plasmids similar to pDV45 and pTMSA1088. Additionally
available sequence data (from Genbank) of further IncK
plasmids harbouring blaCMY-2 were included into this com-
parison. Results revealed a high level of similarity: The
amount of differences varied between 0 and a maximum of
20 genes. Nevertheless the majority of investigated plasmid
sequences exhibited variations in 0 up to 2 genes. Add-
itional blaCMY-2-containing IncK2 plasmids sequences from
previous studies conducted in Europe showed identical al-
lele pattern to plasmid sequences from this study or dif-
fered by a maximum of 4 alleles in pairwise comparisons to
plasmids from Germany (Fig. 3).
IncI1-Iα plasmids
Further replicon typing by the PlasmidFinder software
revealed in 81 isolates the presence of an IncI1 sequence
(Additional file 1: Table S1). This replicon sequence and
blaCMY-2 were found on one contig in 32 isolates. For
another 29 isolates, this linkage was confirmed by align-
ments to reference sequences of IncI1 plasmids. Thus,
61 isolates (human n = 17; chicken n = 20; pig n = 2;
turkey n = 1; chicken meat n = 16; turkey meat n = 4;
pork n = 1) carried blaCMY-2 on IncI1 plasmids. The
existing pMLST scheme for IncI1 plasmids was used to
classify these plasmids into different backbone lineages:
pST12 (n = 39), pST2 (n = 12), pST43 (n = 2), pST23,
pST27, pST26, pST36, pST55, pST240, pST241, and
pST242 (each n = 1). Plasmids of pST12 presented two
types of the blaCMY-2 integration into the plasmid back-
bone: IncI1 pST12a (n = 25) and IncI1 pST12b (n = 12).
The plasmid backbone of four isolates, identified as
pST12 with blaCMY-2, could not be determined.
IncI1 pST12a plasmids (chicken/broiler n = 12; human
n = 5; pig n = 1; turkey n = 1; chicken meat n = 6) revealed
a high similarity (98.5–99.8% pairwise identity) to plasmid
pCVM29188_101 (Genbank accession no: NC_011077.1;
101 kb) from a Salmonella enterica isolate of poultry ori-
gin (USA, 2003) and only differed from that by absence of
a 2462 bp ISEc22 in the pilus region. The direct integra-
tion site of blaCMY-2 and the flanking genes differed in
comparison to the genetic environment of blaCMY-2 found
in IncI1 pST12b plasmids similar to p12-4374_96 (Genbank
accession no: CP012929.1) (Fig. 2a). Plasmid
pCVM29188_101 contained a 3915 bp sized fragment
(ISEcp1- blaCMY-2 - blc - sugE) that was integrated into the
yagA gene. In plasmid p12-4374_96 the blaCMY-2 fragment
was 3123 bp in size and contained ISEcp1- blaCMY-2 and a
65 bp truncated version of blc. The integration site of this
blaCMY-2 fragment is located in the reading frame for a
hypothetical/uncharacterized protein. In addition, insertions
of MGEs were observed in eight isolates of the type IncI1
pST12a (Additional file 6: Table S2).
IncI1 pST12b plasmids (human n = 1; chickens n = 5;
chicken meat n = 3; turkey meat n = 3) exhibited a high
level of sequence identity (93.7–99.9% pairwise identity)
with a previously described 96 kb plasmid (p12-4374_96:
Genbank accession no: CP012929.1) from a human clin-
ical Salmonella strain from Canada in 2012 [20]. Unique
integration sites for MGEs were observed in IncI1 plas-
mids of five isolates (Additional file 6: Table S2).
The second most common IncI1-pST was pST2
(humans n = 3; pig n = 1; chicken n = 1; chicken meat
n = 6; pork n = 1), and these plasmids showed high
similarity (nucleotide sequence identity 96.7–99.9%) to
plasmid pC-6 (Genbank accession no: KT186369.1)
from a human urine sample (2009, Denmark). In nine
of the twelve pST2 plasmids, unique integration sites
of MGEs were observed (Additional file 6: Table S2).
Interestingly, only in plasmids of E. coli-ST58 isolates
(no. RL89, no. RL225, no. RL226 and no. 47–16) an
insertion of ISEc12 into the reading frame of a hypo-
thetical protein was found.
The plasmid backbones of IncI1 pST43 (n = 2), pST23,
pST27, pST26, pST36, pST55, pST240, pST241, pST242
(each n = 1) were not reconstructed but the direct genetic
environment of blaCMY-2 in these plasmids was identical
to the ISEcp1-blaCMY-2-blc-sugE structure (Fig. 2a).
IncA/C plasmids and chromosomal integration of blaCMY-2
Replicon sequence for IncA/C group and blaCMY-2
gene were found on the same de novo assembled
contig of four isolates (humans n = 2; turkey meat
n = 1; pork n = 1). The contigs and aligned reads
showed high resemblance (up to 98.9% nucleotide se-
quence identity at 90.9% coverage) to the 160 kb-IncA/C
plasmid pSAN1–1736 from Salmonella enterica from bo-
vine skin (GenBank accession no. CP014658.1). S1-PFGE
of a transconjugant of isolate no.761–14 confirmed the
presence of a blaCMY-2-carrying IncA/C plasmid with an
estimated size of 170 kb. The blaCMY-2 gene was in all four
isolates flanked by ISEcp1 upstream and blc and sugE
downstream (Fig. 2a).
For ten (6.1%) of the 164 CMY-2-producing E. coli isolates
(humans n = 7; turkeys n = 2; pig n = 1) the blaCMY-2 gene
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was found to be integrated into chromosomal genes.
As expected blaCMY-2 transfer by broth mate conjuga-
tion was unsuccessful for these isolates. The integra-
tion of blaCMY-2 appeared for eight of ten isolates at
a unique site and two isolates (no. 90–16, 216–16) at
the same site in the chromosome (Fig. 2b). Four of
these eight isolates (no. 501–16, 502–16, 509–16 and
739–12) showed a twice as high coverage of the
ISEcp1-blaCMY-2 sequence compared to adjacent se-
quence regions, indicating a second integration site of
blaCMY-2. Detailed analysis of the contigs and reads
revealed for these four isolates the same additional
blaCMY-2-containing genetic environment (Fig. 2c): IS4
was adjacent to the ISEcp1-blaCMY-2 sequence;
downstream of blaCMY-2 a truncated blc gene (Δblc)
was observed, which was followed by a truncated yggR
gene (ΔyggR) and a Shigella flexneri 2a SRL pathogenicity
island-like region (95% identity). This conserved structure
was identical to the previously reported genetic environ-
ment TN44889 of blaCMY-2 (GenBank accession no.
FM246884) and described to be chromosomally integrated
by Fang et al. [18, 21]. However, a direct chromosomal
integration of the additional blaCMY-2-containing genetic
environment could not be confirmed in the four isolates
due to the above mentioned mobile genetic elements
being adjacent to this sequence.
In ten further isolates (humans n = 5; turkey n = 1; pigs
n = 2; cattle n = 1; turkey meat n = 1) we found only the
Fig. 3 Minimum spanning tree of IncK2 plasmid sequences based on a maximum common genome approach using a gene-by-gene comparison in
SeqSphere+ (v. 4.0.1, Ridom GmbH, Münster, Germany). We included 67 genes for this comparison. Previously published plasmids not from this study
(Germany) are indicated by arrows
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putative, chromosomally integrated blaCMY-2-environ-
ment described by Fang et al. [21]; plasmid replicons
were not identified. Likewise no transfer of bla
CMY-2
by broth mate conjugation appeared. In addition,
these isolates showed a nucleotide sequence down-
stream of TN44889 identical to the draft genome of
E. coli Co6114 (GenBank accession no. CP016034.1)
(Fig. 2c) [22].
Discussion
In the present study, we compared core genome se-
quences and plasmid sequences of 164 blaCMY-2-har-
bouring E. coli isolates from meat products (n = 63),
livestock animals (n = 55), and human patients (n = 46)
to assess national or international transmission of
CMY-2-producing strains or bla
CMY-2
-carrying plasmids.
Until today, only a few NGS-based transmission analyses
of CMY-2-producing E. coli across sectors have been
published despite knowing prevalence rates of more
than 20% in poultry and poultry meat [7, 9, 10]. In hu-
man patients in Europe, ca. 1% of the 3rd generation
cephalosporin-resistant E. coli produce CMY-2 [5, 23,
24]. However, in recent studies from Asia much higher
rates and an increasing trend among 3rd-generation
cephalosporin-resistant E. coli isolates have been re-
ported [25, 26]. Moreover, studies from Denmark,
Norway and the Netherlands suggest that blaCMY-2
transmission along the food chain is probable due to ei-
ther horizontal transfer events or clonal spread [7, 9,
10, 27]. Interestingly, whole genome analyses of
ESBL-producing E. coli-ST410 that were found in vari-
ous sources (human patients, healthy humans, livestock
animals, pets and wastewater samples) indicated a high
stability of this clonal lineage and a transfer between
different reservoirs [27, 28].
Distribution and proportion of clonal lineages – MLST
and cgMLST
In this study MLST analysis was done first to provide an
overview about the present CMY-2-E. coli population
structure, and to enable the comparison with results of
previous studies. The 164 CMY-2-producing isolates
could be assigned to 59 different STs, and the isolates
from human patients showed a higher ST variety than
the isolates from livestock animals or meat products
(Table 1). The more frequently observed STs, e.g. ST38
(n = 19), ST131 (n = 14), ST117 (n = 14), and ST69 (n = 8),
were also found to be prevalent in studies on
ESBL-producing E. coli from retail poultry meat, livestock
animals and human patients indicating a successful spread
of clonal lineages independent from distinct resistance
genes [3, 29]. These STs were previously described in
other European countries (Norway, Denmark, Sweden,
Switzerland and Netherlands) demonstrating the high
variability of blaCMY-2-harbouring E. coli lineages in all
sources (human/livestock/food) [7–9, 30]. Interestingly,
we found CMY-2-producing E. coli-ST131 in equal pro-
portions in human patients (n = 6) and chickens (n = 6)
and in some meat products (n = 2). In contrast,
ESBL-producing E. coli-ST131 isolates have been found in
previous studies only occasionally in samples of animal
origin [7, 31]. On the other hand, CMY-2-producing E.
coli-ST38 isolates were found exclusively in poultry and
poultry meat, whereas this ST has been rarely described in
ESBL-producing isolates from humans [11].
A putative clonal transfer along the food chain cannot
be drawn from results of typing methods with a compar-
ably low discrimination such as MLST, even in combin-
ation with additional data, such as resistance pattern,
plasmid replicon type and beta-lactamase gene presence
[10]. Hence, we conducted a genome-wide gene-by-gene
comparison. The clustering of isolates in our cgMLST
scheme was in good concordance with their respective ST
groups, but not always identical (e.g. ST10, Fig. 1). ST10
E. coli isolates were noticeable less genetically related than
isolates of other STs. This high diversity within ST10 is
known and can be explained by the chosen most common
MLST scheme (“Warwick scheme”) and the correspond-
ing housekeeping genes, which are not sufficiently dis-
criminative for ST10 compared to the housekeeping genes
from the two other available MLST schemes (“Pasteur and
Michigan scheme”) [32–35]. This highlights the import-
ance of using typing techniques with a higher discrimin-
ation than MLST to avoid wrong assumptions about
genetic relatedness or transmission events. Nevertheless,
we used the ST nomenclature to enable an international
comparison and a differentiation of isolates that grouped
together in our cgMLST scheme.
Within a ST, isolates from human patients mostly
showed a larger distance to isolates from livestock or
food, but all seemed to have a common ancestor. Spor-
adic clonal transmission events between different
sources (human, livestock, food) in the past followed by
parallel independent micro-evolution within the differ-
ent sources might explain this differentiation between
isolates from human and livestock/food isolates [3].
In fact, only within ST1463 and ST131 a very high
similarity of isolates from human and animal/food
origin was detected in cgMLST and in subsequently
performed SNP-based analysis (Additional file 3:
Figure S2b). Since these isolates were either from the
same geographical region (federal state) or from the
same period of time (6–12 month distance), a clonal
transmission seems likely. Recently, a research group
from Norway reported nearly identical strains of
CMY-2-producing E. coli-ST38 (SNP differences 1–13)
from chickens and from human patients indicating a
clonal transmission as well [9].
Pietsch et al. BMC Genomics  (2018) 19:601 Page 9 of 17
Furthermore, we found a close relationship of isolates
from poultry and poultry meat products, especially for E.
coli isolates of ST117, ST3778 and ST429 (Additional file 3:
Figure S2a,d). The subsequently performed SNP analysis of
isolates of ST117 and ST3778 revealed high similarities
with 0 to 40 SNPs differences between the isolates. The
identified numbers of discriminating SNPs are equal or
marginally higher than SNP differences reported previously
from isolates derived from clonal outbreaks [10, 36]. In pre-
vious studies, epidemiologically linked isolates exhibited
SNPs ranging from ≤6, (isolates of a big German EHEC
outbreak) ≤ 4 (epidemiologically linked cases of E. coli
O157 from Scotland) or ≤ 23 (E. coli O157 pork-associated
outbreak in Alberta, Canada) [36–39].
In a study by Mellmann et al. a threshold of < 11
alleles difference in a pairwise comparison of isolates
was used to identify nosocomial transmissions of E. coli
in an ad-hoc cgMLST analysis (based on 2325 alleles)
[40]. Applying this threshold to the analyzed ST429 iso-
lates with blaCMY-2, the relationship of nearly all isolates
would indicate clonal transmission. Taken into consider-
ation that plasmid analyses of these isolates also showed
highly similar plasmid sequences to the p486–16 plas-
mid sequence, a clonal transmission of an E. coli ST429
strain carrying a blaCMY-2-carrying IncK2 plasmid seems
likely. This supports the hypothesis of clonal transmis-
sion of blaCMY-2 along the poultry production chain and
across sectors. The study design did not enable a direct
observation of individual animals from breeding to
slaughter, whereas this argument remains speculative to
a certain extent. However, veterinary studies in other
countries support this hypothesis. In the Danish conven-
tional broiler production, the spread of ESBL-producing
E. coli clones and ESBL gene-carrying plasmids were ob-
served in imported broiler parent flocks, despite cepha-
losporins have been never approved for use in poultry
[41]. Furthermore, a relatively stable colonization with
CMY-2-producing E. coli was observed in a Norwegian study
through the whole broiler production chain from grandpar-
ent animals to retail meat [23]. Cross-contaminations during
the successive fattening of several herds in the same stable
due to insufficient cleaning and cross-contaminations in big
slaughterhouses, where animals from many farms were proc-
essed, facilitate the spread of distinct clones [42].
Resistance and virulence
Studies on ESBL-producing E. coli of human origin re-
ported rates of 60–70% fluoroquinolone resistance [11, 43].
Our data showed that 43.5% of the blaCMY-2-harbouring
isolates from human origin were resistant to ciprofloxacin.
Differences in the observed fluoroquinolone resistance rates
could be explained by the occurrence of different propor-
tions of E. coli-ST131 in ESBL-E. coli compared to
CMY-2-E. coli [12]. The prevalence of E. coli-ST131 is
observed up to 70% among ESBL-positive E. coli associated
with nosocomial or ambulant urinary tract infections [12].
Further, CMY-2-producing E. coli-ST131 isolates belong
mainly to the fluoroquinolone-susceptible ST131 clade B
(fimH22; see also next chapter) and not to clade C (fimH30);
the latter comprises mostly strains resistant to fluoroquino-
lones [12]. However, rates of fluoroquinolone-resistant
CMY-2-E. coli from livestock animals or meat products were
comparable to the rates of resistance to nalidixic acid and
ciprofloxacin among E. coli from broilers in Sweden, but no-
ticeable lower than in human E. coli isolates [44].
The recently described colistin resistance gene mcr-1
was observed additionally in twelve CMY-2-positive E.
coli strains from this study in chicken (n = 3), pig (n = 5),
turkey (n = 1) and chicken meat products (n = 3). Mcr-1
in Germany is found predominantly in the poultry pro-
duction chain [45]. The higher number of findings of
mcr-1 in isolates from pigs compared to isolates from
chicken in the present study is most likely biased by the
isolate selection process for this study.
In addition, in one isolate from a diseased pig (no. 6–16,
ST10, serotype O141:H49) analysis exhibited the presence
of stx-2. Shiga toxin-production has been rarely described
in ESBL/AmpC-producing E. coli so far [46, 47].
CMY-2-producing E. coli-ST131
We identified a substantial amount of E. coli-ST131 iso-
lates (human patients 6/46, 13.0%; poultry 6/45, 13.3%;
food 2/63, 3.2%), collected from 2010 till 2016. Regard-
ing ESBL-producing E. coli, ST131 is the most frequent
ST in humans but occurs only sporadically in pets, live-
stock or wild animals (0–1.8% of 3rd generation
cephalosporin-resistant E. coli) [3, 11, 12]. All but one
CMY-2-producing E. coli-ST131 isolates from the
present study harboured fimH22 and clustered in clade
B. The single non-fimH22 isolate (no. 177–10) belonged
to the successful ST131 subclone H30-Rx and carried
the putative chromosomally encoded ESBL gene
blaCTX-M-15. The comparison of 15 published whole gen-
ome sequences of E. coli-ST131 isolated between 2008
and 2017 with blaCMY-2, using the ad-hoc cgMLST
approach, showed that nine isolates from other countries
likewise contained fimH22 and differed in 3 to 113
target genes from CMY-2-producing E. coli-ST131
isolates from this study (Additional file 4: Figure S3).
The affiliation of our CMY-2-producing E. coli-ST131
into clade B (fimH22) in contrast to the ESBL-producing
E. coli-ST131 of clade C (ST131-O25b fimH30-R/
fimH30-Rx) suggests a CMY-2-producing E. coli-ST131
population with an independent evolution in different
reservoirs. ST131-O25b with ESBL-production often oc-
curs in human patients and isolates might be adapted to
colonization and infection in the human bladder [48]. In
contrast, CMY-2-producing E. coli-ST131 isolates were
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described rarely in humans [31, 49, 50] and recent stud-
ies from Germany, the Netherlands and Denmark re-
ported only a few isolates in poultry [7, 17]. The much
higher proportion of ST131 in our CMY-2-producing E.
coli collection remains unclear; we did not recognize any
obvious bias in the sampling strategy of the underlying
studies for the isolate collection which might have influ-
enced enrichment for ST131 clade B (fimH22) isolates in
our sample.
Plasmid structures
The integration of the blaCMY-2 gene occurred in a
narrower spectrum of genetic structures and plasmid
backbones in relation to the comparably high variety of
clonal lineages. blaCMY-2 has been frequently reported
on IncI1, IncK and IncA/C plasmids in E. coli and sporadic-
ally on IncF, IncX, IncI2 or IncHI2 plasmids [21, 51–53].
However, in our collection we only identified IncI1, IncK
and IncA/C plasmids carrying blaCMY-2. The most
prevalent plasmid types were of incompatibility groups
IncK2 (n = 76) and IncI1 (n = 61). Previous studies reported
that dissemination of blaCMY-2 in E. coli is mainly driven by
plasmids of these two Inc groups within Europe [7–9, 54].
In contrast, IncA/C plasmids seem to play a more promin-
ent role in the spread of blaCMY-2 in North America [18,
55–57]. In a Dutch study all blaCMY-2-harbouring plasmids
belonged to IncA/C indicating the importance of clonal
spread in isolated populations such as broiler stocks [58].
Our analysis revealed that all IncK plasmids belonged to
the recently described IncK2 type [8]. Sequence identity
among these plasmids was high and the most frequent plas-
mid backbone structures were similar (98.6–100% identity)
to two previously published plasmids pTMSA1088 (n = 13)
(KR905386.1) and pDV45 (n = 54) (KR905384.1) [8]. Plas-
mids similar to pTMSA1088 were found in isolates of ST38
(n= 11), ST10 (n = 1) and ST117 (n= 1). This specific ST38/
pTMSA1088-like combination has been reported before in
broiler meat production of several countries (Netherlands,
Denmark, Norway, Sweden) and raised the discussion if a
highly conserved IncK2 plasmid carrying blaCMY-2 is genet-
ically linked to ST38 [7–9]. In a direct gene-by-gene com-
parison of all pTMSA1088-like and pDV45-like plasmids
from the present study with blaCMY-2 plasmids from the
Netherlands, Denmark, Norway and Switzerland, we con-
firmed the expected high relatedness. The low number of
variations observed in the genes of these plasmids indicates
a horizontal transmission, and for the ST38/pTMSA1088-
like combination a dissemination of the plasmids linked to a
clonal transmission across the European broiler production
is highly probable (Fig. 3) [7, 8, 10, 59]. Moreover, a modifi-
cation of the plasmid backbone structure in comparison to
plasmid pDV45 was observed in six ST429 isolates
(Additional file 5: Figure S4). The occurrence of this back-
bone structure only in ST429 suggests a clonal transmission
linked to the plasmid. Identical IS insertions in the plasmids
and SNP-based comparisons of the core genomes
(Additional file 3: Figure S2d) support this suggestion. The
modified plasmid backbone structure contained additional
genes encoding a plasmid segregation system (stbAB) which
enables a stable vertical transmission during cell division as
well as horizontal transmission (conjugation), and thus it
promotes efficient blaCMY-2 plasmid propagation [60].
In contrast to the IncK2 plasmids, we detected more di-
verse IncI1 plasmid structures. IncI1 plasmids carrying
blaCMY-2 were reported worldwide and differ considerably
in their plasmid backbone structures [7, 18, 61, 62]. In the
present study most IncI1 plasmids could be assigned to
pST12 (39/61) and pST2 (12/61). The majorities of IncI1
plasmids of each respective pSTs were highly similar in
their conserved backbone structures and differed only in a
few SNPs or an MGE insertion. Among IncI1-pST12 plas-
mids two different types (IncI1 pST12a and IncI1 pST12b)
were identified differing in the direct genetic surrounding
of blaCMY-2 and an additional plasmid addiction system.
These differences in the integration site of blaCMY-2 indi-
cate two independent mobilization events into highly
similar plasmid backbones.
In general, the distribution of blaCMY-2-carrying IncK2
and IncI1 plasmids was heterogeneous among isolates
from human patients, livestock animals and food as well
as in various E. coli-STs (Fig. 1) which supports the hy-
pothesis that the horizontal transfer via plasmids plays
the major role for transmission of blaCMY-2 between the
reservoirs. Given the capability of these plasmids to
transfer themselves within E. coli and into other Entero-
bacteriaceae genera, the ingested blaCMY-2-carrying
strains from meat products might transfer their resist-
ance gene to the human host-adapted strains [63].
blaCMY-2 in the chromosome
In 20 isolates, mainly from human patients (12/20), the
localization of blaCMY-2 on the chromosome was ei-
ther confirmed or suspected to be chromosomal. While
for ten isolates blaCMY-2 was found to be located on the
chromosome by sequence and read analysis, for further
ten isolates the localization of blaCMY-2 on the chromo-
some was suspected due to the identity to a previously
described blaCMY-2 structure: A recent publication from
China reports the integration of this blaCMY-2-containing
fragment TN44889 into the chromosome of E. coli
strains (9/469) isolated from companion and livestock
animals [21]. It is known that blaCMY-2 can integrate into
the chromosome of Proteus mirabilis or S. enterica but
only in few studies isolates with blaCMY-2 integrated into
the chromosome of E. coli were identified [64, 65]. The
variety of confirmed and presumable chromosomal inte-
gration sites and the differences in the blaCMY-2genetic
environments in general point towards independent
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events of chromosomal integration of this resistance gene.
However, the high similarity (2 to 3 SNP-differences) of
three ST1196 isolates from livestock animals from our
collection (Additional file 3: Figure S2c) with an identical
insertion site of ISApl1 suggested propagation by clonal
transmission in this specific setting. The reason for the
comparable high number of isolates from humans (n = 12)
with chromosomal blaCMY-2 integration sites in this study
remains unknown.
Limitations
The study has several limitations to be considered. First,
the sampling of the 164 CMY-2-producing E. coli iso-
lates was conducted over a period of 5 years in the scope
of different studies (human patients, livestock animals,
food) of the national research project RESET. Regarding
studies on livestock animals, we selected only one isolate
from each farm or isolates from the same farm with dif-
ferent properties, e.g. different phylogenetic groups, to
achieve a preferably heterogeneous sample of the distri-
bution of blaCMY-2-carrying isolates in German farms.
Therefore, the selection of the isolates, especially from
broiler production, is not completely randomized but as
diverse as possible. Second, the long sampling period of
five years was necessary due to the comparably low
prevalence of CMY-2-producing E. coli among
3rd-generation cephalosporin-resistant E. coli from hu-
man infections and colonizations. Third, putative links
between isolates from animals, food and humans could
not be further elucidated due to limited clinical data of
patients and missing information on origin and transport
ways of livestock animals and meat products.
Conclusions
The whole genome sequence analysis of 164 CMY-2-produ-
cing E. coli isolated from human patients, livestock animals
and meat products in Germany revealed a high diversity of
STs across all sources; most frequent types were ST38,
ST131 and ST117. The CMY-2-producing ST131 isolates
from human patients and livestock animals belonged to an-
other sub-lineage (clade B; fimH22) than the worldwide
prevalent multidrug-resistant and ESBL-producing ST131-
O25b lineage (clade C; fimH30) known from humans. Our
data suggest that clonal transmission of blaCMY-2 is a rare
event while the horizontal transfer of temporally stable blaC-
MY-2-carrying IncK2 and IncI1 plasmids is more likely the
dominant way of transmission between humans and animals.
At present, CMY-2-carrying E. coli are rarely detected from
human infections in Germany and Central Europe. However,
the large reservoir of blaCMY-2 -carrying plasmids in livestock
animals, especially poultry, poses a serious future risk of a
more pronounced potential of CMY-2-producing E. coli iso-
lates causing infections in humans and animals.
Methods
Bacterial isolates
We included 164 CMY-2-producing E. coli from Germany
collected 2008–2016. The majority of isolates (n = 149)
was collected and isolated between 2011 and 2014 in the
scope of the national research consortium “RESET”
(www.reset-verbund.de) by different project partners: Rob-
ert Koch Institute (RKI), German Federal Institute for Risk
Assessment (BfR), Friedrich-Loeffler-Institut (FLI) and
Freie Universität Berlin (FU). No concrete sampling plan
for the collection of the isolates was developed; rather all
isolates were collected in the scope of different studies in-
cluding isolates from healthy livestock animals, diseased
livestock animals, food samples and human patients, and
represent therefore a random collection of CMY-2-produ-
cing E. coli isolates from Germany (Additional file 1: Table
S1). To enable a higher comparability of studies on differ-
ent animal species, the RESET consortium harmonized
protocols for sampling and basic phenotypical and geno-
typical analyses were developed in advance. FU provided
50 CMY-2-producing E. coli isolates from chicken (n = 9
in 2011 and n = 28 in 2012), turkey (n = 1 in 2012 and n =
3 in 2014), pig (n = 6 in 2011 and n = 2 in 2012) and cattle
(n = 1 in 2012) for WGS analysis. These isolates were col-
lected in longitudinal- and cross-sectional studies in dif-
ferent livestock farms during the years 2011–2014 [66–
70]; only isolates from unique production sites were in-
cluded. In addition, BfR provided 63 CMY-2-producing E.
coli isolates that were identified from 2500 food samples
of different origins and matrices, collected and investi-
gated by different German state laboratories, in the scope
of a cross-sectional study on ESBL-E. coli in foodstuff in
Germany (unpublished data). In brief, the 63 isolates were
from chicken meat samples (n = 53), turkey meat samples
(n = 7) and pig meat samples (n = 3), and were isolated be-
tween 2011 and 2013. Furthermore, FLI identified five
CMY-2-producing E. coli isolates from diseased livestock
animal (chicken n = 3, pig n = 1 and cattle n = 1) that were
included in the present study [71]. These five isolates were
detected between 2008 and 2015 within the GERM-Vet
program, a monitoring program collecting data of resist-
ance of pathogenic bacteria and including only isolates
from clinically diseased, non antibiotically pretreated ani-
mals. Finally, CMY-2-producing E. coli from human clinical
samples (n = 46) were collected by RKI between 2008 and
2016. These isolates were obtained from different studies
[5, 11] or were sent from German laboratories to RKI for
confirmatory diagnostics (Additional file 1: Table S1).
Antimicrobial susceptibility testing and resistance gene
screening
Susceptibilities to ampicillin, cefotaxime, ceftazidime,
cefoxitin, ciprofloxacin, imipenem and meropenem were
tested for all E. coli isolates by disk diffusion (Oxoid Ltd.,
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Basingstoke, United Kingdom) according to the manufac-
turer’s instructions, and interpretation was done according
to EUCAST criteria (http://www.eucast.org/clinical_break-
points; v7.1). The phylogenetic group of the E. coli isolates
was determined by a PCR-based assay [72]. The presence
of β-lactamase genes (blaTEM, blaSHV, blaCTX-M-group-1-2-9,
and blaCMY) was confirmed by PCR and sequencing as
previously described [73, 74]; only CMY-2 positive isolates
were included in the present study.
blaCMY-2 transferability and plasmid typing
A broth mate conjugation assay was performed for 60 ran-
domly selected isolates using the sodium azide-resistant E.
coli K12 J53 recipient strain [75]. Transconjugants were
selected on Lysogeny-Broth (LB) agar supplemented with
200 mg/L sodium azide and 100 mg/L ampicillin. Selected
transconjugants were tested for the presence of blaCMY-2
by PCR as previously described, and the plasmid sizes
were determined using S1 nuclease-restriction followed by
pulsed-field gel electrophoresis (PFGE) [73, 76]. Plasmidic
DNA was extracted by the Qiagen Plasmid mini Kit
(Hilden, Germany) and followed by PCR-based replicon
typing (PBRT-Kit, Diatheva, Italy).
Whole genome sequencing and sequence reconstruction
All 164 blaCMY-2-containing E. coli isolates were se-
quenced using an Illumina MiSeq platform (Illumina,
San Diego, U.S.A). Isolate preparation, DNA extraction
and sequencing were carried out by RKI, BfR and LGC
Genomics GmbH (Berlin, Germany). At the RKI gen-
omic DNA of 58 E. coli isolates was extracted using the
DNA Blood & Tissue Kit according to the manufac-
turer’s instruction (Qiagen, Hilden, Germany), followed
by library preparation, using Nextera XT library (Illu-
mina, USA), and sequenced on an Illumina MiSeq plat-
form using the MiSeq v3 reagent kit (Illumina, USA)
with 2 × 300 bp paired-end reads. Furthermore, 62 E. coli
isolates were sent to the company LGC Genomics that
performed DNA extraction and sequencing, using the
Illumina MiSeq platform MiSeq v3 reagent kit (Illumina,
USA) with 2 × 300 bp paired-end reads. At the BfR, ex-
traction of genomic DNA of 44 isolates was carried out
using PureLink® genomic DNA Kit from Invitrogen™ (by
ThermoFisher Scientific).
The following RKI internal procedure was used: The
resulting raw reads were processed by Trimmomatic (v.
0.0.9; default parameters except maxinfo 15:0.5) and as-
sembled by A5-miseq (v. 0.0.9 beta; default parameters)
[77, 78]. The quality of the read data was assessed by
using the PHRED scores. Raw sequence data had an aver-
age PHRED score above 30. The average read quality was
increased by trimming to a PHRED score of above 35.
Phylogenetic analyses
All contigs were submitted to the CGE Finder Series
(Centre for Genomic Epidemiology, Technical University
of Denmark (DTU), https://cge.cbs.dtu.dk/services/).
Different analysis tools (MLST 1.8, pMLST 1.4, Plasmid-
Finder 1.3, ResFinder 2.1, VirulenceFinder 1.5) were ap-
plied to extract the multilocus sequence type (ST)
according to Wirth et al., plasmid multilocus sequence
type (pST), plasmid replicon types and information on
genes mediating resistance to β-lactams and fluoroqui-
nolones and distinct virulence genes (stx1/2), respect-
ively [32, 79–83].
For deeper phylogenetic analysis (i) a gene-based com-
parison approach and (ii) a single nucleotide polymor-
phisms (SNP)-based mapping analysis were performed.
For this purpose, an ad-hoc core genome multilocus se-
quence typing scheme (cgMLST) was created using Seq-
Sphere+ (v. 4.0.1, Ridom GmbH, Münster, Germany) as
described before [84, 85]. E. coli O157:H7 str. Sakai
(GenBank accession no. NC_002695.1) was used as ref-
erence genome and further 43 E. coli genomes from the
National Centre for Biotechnology Information (NCBI)
were selected as query genomes. Open reading frames
(ORFs) were predicted and extracted by using the
cgMLST Target Definer v1.4 of SeqSphere+, resulting in
2547 shared genes among these isolates, which were de-
fined as core genome (Additional file 7: Table S3). Obtained
cgMLST target gene variants were used to visualize the
phylogenetic distance by calculating a Neighbour-Joining
tree (parameters were: pairwise ignoring missing values; %
columns difference) based on the distance matrix of the
core genome differences. The tree was visualized using
iTOL (v. 3.5.4) (http://itol.embl.de/) [86].
Isolates which presented a high relationship in the
cgMLST scheme were further investigated by single nu-
cleotide polymorphisms (SNP)-based mapping analysis.
A suitable reference was identified using refRank as de-
scribed previously (https://gitlab.com/s.fuchs/refRank)
[87]. Paired-end reads were mapped to the identified
best reference genome for respective selected isolates
(ST131: NZ_CP019008.1; ST117/ST3778: NZ_CP019903.1;
ST1196: NC_020518.1; ST429: NC_013654.1) by BWA-SW
(v. 0.7.15-r1140; default parameters) [88]. Variant calling
was performed using VarScan (parameter: min-coverage
10; min-reads2 6; min-avg-qual 20; min-var-freq 0.8;
min-var-for-hom 0.75; p-value 0.01; strand-filter 0) [89].
SNPs were filtered using SNPfilter (https://gitlab.com/
s.fuchs/snpfilter) [87]. Maximum likelihood trees were cal-
culated using RAxML with a GTR GAMMA nucleotide
model (rapid hill-climbing, using 100 starting trees) [90].
Phylogenetic trees were visualized by iTOL (v. 3.5.4).
All E. coli isolates of ST131 were analysed for the pres-
ence of fimH gene by aligning to a fimH database using
SeqSphere+ [14, 91].
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Plasmid analysis
Regarding the identification of the blaCMY-2-harbouring con-
tigs, all contigs were aligned using Geneious (v. 10.0.5,
Biomatters Ltd., Auckland, New Zealand) to the blaCMY-2
gene (GenBank accession no. X91840.1). Contigs containing
blaCMY-2 were hereafter aligned to several fully sequenced
blaCMY-2-carrying plasmids of different Incompatibility
groups (Inc) from GenBank using Geneious to identify high-
est resemblance to a reference plasmid: IncK2: pDV45
(GenBank accession no. KR905384.1), pTMSA1088
(GenBank accession no. KR905386.1); IncI1: p12-4374_96
(GenBank accession no. CP012929.1), pC-6 (GenBank ac-
cession no. KT186369.1), pCVM29188_101 (GenBank ac-
cession no. NC_011077.1); IncA/C: pSAN1–1736 (GenBank
accession no. CP014658.1).
All contigs of a respective isolate were aligned to the
identified best fitting reference plasmid. Additionally,
read alignment of trimmed reads (Trimmomatic v. 0.0.9;
default parameters except maxinfo 15:0.5) to the selected
reference plasmid using the Geneious (v. 10.0.5) mapper
(medium-low sensitivity, no iterations) was performed.
The results obtained were then compared by aligning
with the respective reference plasmids and examined for
MGEs, using the ISfinder (https://www-is.biotoul.fr/
index.php) [92].
To compare IncK plasmids from this study with avail-
able IncK plasmids carrying blaCMY-2 from nucleotide
sequence databases, a maximum common gene ap-
proach was conducted. For that purpose ORFs from the
blaCMY-2-carrying IncK2 plasmid pDV45 were predicted
and extracted by using the cgMLST Target Definer v1.4
of SeqSphere+, resulting in 89 genes, of which 67 were
found in all the plasmids to be compared. Target gene
distance was visualized by a minimum spanning tree
(based on 67 targets, pairwise ignoring missing values).
Nucleotide sequence accession numbers
Sequence data were submitted to the European Nucleo-
tide Archive (http://www.ebi.ac.uk/ena) under the study
accession number PRJEB23663.
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Additional file 3: Figure S2. SNP-based maximum-likelihood-trees of
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MDR_56) based tree, calculated with RAxML, GTR Gamma and rapid hill-
climbing and 100 starting trees. b: Maximum-likelihood-tree of ST131 O25b:H4
fimH22 isolates. SNPfilter (d = 0, reference: NZ_CP019008.1 E. coli strain Eco-
l_AZ159) based tree, calculated with RAxML, GTR Gamma and rapid hill-
climbing and 100 starting trees. c: Maximum-likelihood-tree of ST1196 isolates.
SNPfilter (d = 0, reference: NC_020518.1 E. coli str. K-12 substr. MDS42) based
tree, calculated with RAxML, GTR Gamma and rapid hill-climbing and 100
starting trees. d: Maximum-likelihood-tree of ST429 isolates. SNPfilter (d = 0,
reference: NC_013654.1 E. coli strain SE15) based tree, calculated with RAxML,
GTR Gamma and rapid hill-climbing and 100 starting trees. (PDF 174 kb)
Additional file 4: Figure S3. Minimum spanning tree of E. coli ST131
isolates from this study and INSDC and Enterobase based on an ad-hoc cgMLST
including 2547 alleles. All fimH alleles and blaCMY and blaCTX-M genes are color-
coded. Isolates from this study are marked with a red ring. (PDF 971 kb)
Additional file 5: Figure S4. Comparison of plasmid sequence p486–16
with other IncK2 plasmids created with EasyFig v.2.2.2 (http://
mjsull.github.io/Easyfig/). Used reference plasmid sequence were
pTMSA1088 (Genbank: KR905386.1), pDV45 (KR905384.1). (PDF 38 kb)
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